News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
693,970 Results
Type
Article (40755)
Company Profile (299)
Press Release (652916)
Section
Business (205380)
Career Advice (2009)
Deals (35545)
Drug Delivery (93)
Drug Development (81386)
Employer Resources (168)
FDA (16248)
Job Trends (14893)
News (347177)
Policy (32920)
Tag
Academia (2577)
Alliances (49893)
Alzheimer's disease (1272)
Approvals (16193)
Artificial intelligence (145)
Bankruptcy (354)
Best Places to Work (11629)
Biotechnology (212)
Breast cancer (188)
Cancer (1374)
Cardiovascular disease (110)
Career advice (1675)
Cell therapy (287)
Clinical research (65049)
Collaboration (487)
Compensation (260)
COVID-19 (2580)
C-suite (110)
Data (1392)
Diabetes (174)
Diagnostics (6205)
Earnings (85083)
Employer resources (146)
Events (110740)
Executive appointments (394)
FDA (16924)
Funding (431)
Gene therapy (201)
GLP-1 (607)
Government (4430)
Healthcare (18775)
Infectious disease (2673)
Inflammatory bowel disease (115)
Interviews (310)
IPO (16405)
Job creations (3666)
Job search strategy (1429)
Layoffs (424)
Legal (7922)
Lung cancer (201)
Lymphoma (98)
Manufacturing (212)
Medical device (13281)
Medtech (13286)
Mergers & acquisitions (19299)
Metabolic disorders (456)
Neuroscience (1595)
NextGen Class of 2024 (6550)
Non-profit (4496)
Northern California (1698)
Obesity (260)
Opinion (191)
Patents (118)
People (56843)
Phase I (20255)
Phase II (28630)
Phase III (21370)
Pipeline (517)
Postmarket research (2575)
Preclinical (8620)
Radiopharmaceuticals (236)
Rare diseases (264)
Real estate (5978)
Regulatory (22007)
Research institute (2349)
Resumes & cover letters (350)
Southern California (1467)
Startups (3617)
United States (15246)
Vaccines (583)
Weight loss (182)
Date
Today (1)
Last 7 days (590)
Last 30 days (2351)
Last 365 days (35434)
2024 (35264)
2023 (40334)
2022 (51487)
2021 (56034)
2020 (54405)
2019 (46853)
2018 (35304)
2017 (32485)
2016 (31855)
2015 (37924)
2014 (31692)
2013 (26709)
2012 (28881)
2011 (29574)
2010 (27569)
Location
Africa (727)
Arizona (195)
Asia (37959)
Australia (6174)
California (3828)
Canada (1451)
China (307)
Colorado (172)
Connecticut (177)
Europe (81436)
Florida (533)
Georgia (135)
Illinois (384)
Indiana (226)
Maryland (648)
Massachusetts (2983)
Michigan (172)
Minnesota (297)
New Jersey (1110)
New York (1085)
North Carolina (748)
Northern California (1698)
Ohio (148)
Pennsylvania (925)
South America (1107)
Southern California (1467)
Texas (547)
Utah (109)
Washington State (401)
693,970 Results for "adma biologics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ADMA Biologics Announces Partial Paydown of Senior Term Loan Credit Facility
December 20, 2024
·
4 min read
Business
ADMA Biologics Announces First Quarter 2024 Financial Results and Provides Business Update
ADMA Biologics, Inc., an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty biologics, announced its first quarter 2024 financial results and provided a business update.
May 9, 2024
·
18 min read
Business
ADMA Biologics to Report First Quarter 2024 Financial Results on May 9, 2024
ADMA Biologics, Inc., an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty biologics, announced that it will report first quarter 2024 financial results on May 9, 2024, after the U.S. financial markets close.
May 2, 2024
·
2 min read
Press Releases
ADMA Biologics Announces Third Quarter 2024 Financial Results and Provides Business Update
November 8, 2024
·
20 min read
Press Releases
ADMA Biologics to Report Third Quarter 2024 Financial Results on November 7, 2024
October 30, 2024
·
2 min read
Business
ADMA Biologics Announces CFO TransitionExecutive Search Initiated for CFO Replacement
ADMA Biologics, Inc. announced that Brian Lenz, Executive Vice President, Chief Financial Officer & General Manager, ADMA BioCenters will be transitioning from these positions to a consulting role, effective April 1, 2024.
February 28, 2024
·
4 min read
Business
ADMA Biologics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty biologics, today announced its fourth quarter and full year 2023 financial results and provided a business update.
February 28, 2024
·
20 min read
BioMidwest
ADMA Biologics to Participate in the Raymond James Institutional Investor Conference
ADMA Biologics, Inc. announced Adam Grossman, President and Chief Executive Officer, will participate in a fireside chat at the Raymond James Institutional Investor Conference on March 6, 2024, at 11:35 a.m. ET.
March 5, 2024
·
2 min read
BioMidwest
ADMA Biologics Successfully Implements Innovative AI Program, Named ADMAlytics
ADMA Biologics, Inc., an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty biologics, announced the successful initial use of its Artificial Intelligence program, named ADMAlytics.
February 21, 2024
·
5 min read
Press Releases
ADMA Biologics to Participate in the 2024 Cantor Global Healthcare Conference
September 10, 2024
·
2 min read
1 of 69,397
Next
